Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liberia malaria therapeutic efficacy study of artesunate + amodiaquine and artemether + lumefantrine
ACTRN12617001064392Phase 4Completed
- Sponsor
- Ministry of Health, Republic of Liberia
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of artesunate, amodiaquine, artemether and lumefantrine in malaria and Falciparum malaria (PF) (2 arms), sponsored by Ministry of Health, Republic of Liberia. Primary endpoints: Treatment failure rate and Adequate clinical and parasitological response. Started Dec 2017; status: completed.
02
Drugs
artesunateamodiaquineartemetherlumefantrine
03
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on ACTRN12617001064392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001064392.